Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study

被引:97
作者
Bomben, Riccardo [1 ]
Dal Bo, Michele [1 ]
Capello, Daniela [2 ,3 ]
Forconi, Francesco [4 ]
Maffei, Rossana [5 ]
Laurenti, Luca [6 ]
Rossi, Davide [2 ,3 ]
Del Principe, Maria Ilaria [7 ]
Zucchetto, Antonella [1 ]
Bertoni, Francesco [8 ,9 ]
Rossi, Francesca Maria [1 ]
Bulian, Pietro [1 ]
Cattarossi, Ilaria [1 ]
Ilariucci, Fiorella [10 ]
Sozzi, Elisa [4 ]
Spina, Valeria [2 ,3 ]
Zucca, Emanuele [8 ,9 ]
Degan, Massimo [1 ]
Lauria, Francesco [4 ]
Del Poeta, Giovanni [7 ]
Efremov, Dimitar G. [11 ]
Marasca, Roberto [5 ]
Gaidano, Gianluca [2 ,3 ]
Gattei, Valter [1 ]
机构
[1] IRCCS, Ctr Riferimento Oncol, Clin & Expt Oncohaematol Unit, I-33081 Aviano, PN, Italy
[2] Amedeo Avogadro Univ Eastern Piedmont, Div Haematol, Dept Clin & Expt Med, Novara, Italy
[3] Amedeo Avogadro Univ Eastern Piedmont, BRMA, Novara, Italy
[4] Univ Siena, Dept Clin Med & Immunol Sci, Div Haematol & Transplant, I-53100 Siena, Italy
[5] Univ Modena & Reggio Emilia, Div Haematol, Dept Haematol & Oncol, Modena, Italy
[6] Univ Cattolica Sacro Cuore, Haematol Inst, Rome, Italy
[7] Univ Tor Vergata, S Eugenio Hosp, Div Haematol, Rome, Italy
[8] Oncol Inst So Switzerland, Expt Oncol Lab, Bellinzona, Switzerland
[9] Oncol Inst So Switzerland, Lymphoma Unit, Bellinzona, Switzerland
[10] Reggio Emilia Hosp, Haematol Unit, Modena, Italy
[11] ICGEB Outstn Monterotondo, Rome, Italy
关键词
chronic lymphocytic leukaemia; B cell receptor; immunoglobulin genes; prognosis; VARIABLE-REGION MUTATIONS; ANTIGEN-DRIVEN SELECTION; V-H; CD38; EXPRESSION; SOMATIC HYPERMUTATION; ZAP-70; GENE-MUTATIONS; PATHOGENETIC IMPLICATIONS; NATURAL AUTOANTIBODIES; IMMUNOGLOBULIN HEAVY;
D O I
10.1111/j.1365-2141.2008.07469.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A fraction of chronic lymphocytic leukaemia (CLL) cases carry highly homologous B-cell receptors (BCR), i.e. characterized by non-random combinations of immunoglobulin heavy-chain variable (IGHV) genes and heavy-chain complementarity determining region-3 (HCDR3), often associated with a restricted selection of IGVK/L light chains. Such 'stereotyped' BCR occur more frequently in CLL with unmutated (UM) than mutated (M) IGHV genes. We analysed 1426 IG rearrangements (from 1398 CLL cases) by a clustering driven by HCDR3 similarities. Molecular findings were correlated to time-to-treatment (TTT) and presence of known prognosticators. Sixty-nine clusters (319 IG-rearrangements, 22.4%) with stereotyped BCR were identified. Among 30 confirmed clusters (>= 3 IG-rearrangements/cluster), we found 14 novel clusters, of which 11 had M IG rearrangements (M clusters) and predominantly (8/11) used IGHV3 subgroup genes. Recurrent cluster-biased amino acid changes were found throughout IGHV sequences of these 'M clusters'. Regarding clinical outcome: (i) UM CLL from the IGHV1-2/1-3/1-18/1-46/7-4-1/IGKV1-39 cluster had poorer prognosis than UM/M cases, or UM cases using the same IGHV genes but not in clusters; (ii) M CLL from the IGHV3-21/IGLV3-21 cluster had TTT similar to UM CLL, and shorter than M CLL expressing IGHV3-21 but not in cluster. Altogether, our analysis identified additional molecular and clinical features for CLL expressing stereotyped BCR.
引用
收藏
页码:492 / 506
页数:15
相关论文
共 71 条
[71]   Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia [J].
Zenz, Thorsten ;
Doehner, Hartmut ;
Stilgenbauer, Stephan .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (03) :439-453